
Kotak Healthcare Fund Direct Growth is a Equity mutual fund scheme launched on 11 Dec 2023. The current NAV stands at ₹18.7660 as of 12 Nov 2026. From the funds total AUM, its top holdings include Sun Pharmaceutical at 13.01%, J B Chemicals and Pharmaceuticals at 6.23%, Divis Laboratories at 5.95%, Max Healthcare Institute at 5.43%, Cipla at 5.00%
Scheme Overview
- Inception Date : 11 Dec 2023
- AUM : ₹860.75 Cr
- 1Y Returns (CAGR) : 32.92%
- Expense Ratio : 1.04%
- Min. SIP : ₹100
- Min. Lumpsum : ₹100
Returns Calculator
basis annualised returns
Investment Type
SIP Amount
Investment Period
1Y
₹ 6.10 L
3.50%
₹ 6.27 L
8.00%
₹ 7.19 L
32.92%
Total Investment
₹ 6,00,000
Returns
₹ 1,18,528 (32.92%)
Maturity Value
₹ 7,18,528
Disclaimer: Fixed deposits offer guaranteed returns. Mutual fund investments carry market risks; read all scheme-related documents carefully. Past performance does not guarantee future returns.
Direct vs Regular Returns
Sorry, No Data Available at this Moment!
Returns vs Category
Sorry, No Data Available at this Moment!
*The above returns are absolute
Returns Vs Nifty 50
Historical Returns
Sorry, No Data Available at this Moment!
Start SIP with as Low as ₹100.
Historical NAV
Sorry, No Data Available at this Moment!
Asset Allocation
AUM
₹ 860.75 Cr
Cash Holding
-
Equity
-
Cash
-
Debt
-
Other
-
Asset Allocation
AUM
₹860.75 Cr
Cash Holding
-
Equity
-
Cash
-
Debt
-
Other
-
Sector Holdings
as of 31 May 2026
| Sectors | Allocation | Weightage | Value (in Cr.) |
|---|---|---|---|
| Healthcare | 93.92% | ||
| Basic Materials | 4.92% | ||
| Other | 1.16% |
Stock Holdings
as of 31 May 2026
| Name | Allocation | Weightage |
|---|---|---|
![]() S Sun Pharmaceutical | 13.01% | |
![]() J J B Chemicals and Pharmaceuticals | 6.23% | |
![]() D Divis Laboratories | 5.95% | |
![]() M Max Healthcare Institute | 5.43% | |
![]() C Cipla | 5.00% | |
![]() A Acutaas Chemicals | 4.92% | |
![]() F Fortis Healthcare | 4.31% | |
![]() P Park Medi World | 4.20% | |
![]() M Mankind Pharma | 3.18% | |
![]() K Krishna Institute of Medical Sciences | 3.12% | |
![]() A Apollo Hospitals | 2.92% | |
![]() S Sai Life Sciences | 2.90% | |
![]() L Lupin | 2.63% | |
![]() A Anthem Biosciences | 2.44% | |
![]() J Jubilant Pharmova | 2.40% | |
![]() A Aurobindo Pharma | 2.29% | |
![]() M Marksans Pharma | 2.20% | |
![]() A Ajanta Pharma | 2.20% | |
![]() G Glenmark Pharmaceuticals | 2.03% | |
![]() G Gland Pharma | 2.01% | |
![]() L Laurus Labs | 1.95% | |
![]() A Alkem Laboratories | 1.86% | |
R Rubicon Research | 1.80% | |
![]() O Orchid Pharma | 1.70% | |
![]() C Corona Remedies | 1.65% | |
![]() E Emcure Pharmaceuticals | 1.51% | |
![]() R Rainbow Childrens Medicare | 1.48% | |
![]() Z Zydus Life Science | 1.35% | |
![]() T Triparty Repo | 1.29% | |
![]() Y Yatharth Hospital | 1.28% | |
![]() D Dr. Lal Path Labs | 1.26% | |
![]() L Laxmi Dental | 1.18% | |
![]() I Innova Captab | 1.17% | |
![]() M Metropolis Healthcare | 1.09% | |
![]() M Medi Assist Healthcare | 0.22% | |
![]() N Net Current Assets/(Liabilities) | 0.13% |
Fund Comparison
Fund Details
52W High NAV
₹ 18.6460
Min. SIP Amount
₹ 100.00
Min. Lumpsum Amount
₹ 100.00
AUM (in Cr.)
₹ 860.75
Expense Ratio
1.04%
Lock-in Period
No Lock in Period
52W Low NAV
₹ 13.0430
Inception Date
11 Dec 2023
Fund Age
2 Yrs
Benchmark
NIFTY Healthcare TRI
Scheme Type
Open Ended
Stamp Duty
0.005% (from July 1st 2020)
Exit Load
- 0.5% for redemption within 30 Days
Tax Implication
- If you redeem within 1 year, STCG are taxed at 20%; If you redeem after 1 year, and returns exceed ₹1.25 Lakhs in a financial year, LTCG are taxed at 12.5%
Fund Managers
| Name | Qualification |
|---|---|
| Abhishek Bisen | B.A., and MBA (Finance) |
| Dhananjay Tikariha | B.Tech, M. Tech from IIT Madras and PGDM (Finance & Marketing) from IIM Lucknow |
Fund Objective
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors. However, there is no assurance that the objective of the scheme will be achieved .
Risk-O-Meter
Investors understand that their principal will be at
Very High Risk
Risk Scale
Low
Moderately Low
Moderate
Moderately High
High
Very High
AMC Information
Kotak Mahindra Mutual Fund
No. of Schemes
89
Total AUM
₹ 5,61,218.80 Cr
Contact Details
27 BKC, C-27, G Block, Bandra KurlaComplex, Bandra(E),Mumbai - 400 051.
Contact Details
27 BKC, C-27, G Block, Bandra KurlaComplex, Bandra(E),Mumbai - 400 051.
FAQs
When was Kotak Healthcare Fund launched?
What is the current NAV of Kotak Healthcare Fund?
What is the AUM of Kotak Healthcare Fund?
What is the rate of return of Kotak Healthcare Fund?
- In the past 1Y: 32.92%
- In the past 3Y: 0.00%
- In the past 5Y: 0.00%
What is the expense ratio of Kotak Healthcare Fund?
What is exit load of Kotak Healthcare Fund?
What is the portfolio of Kotak Healthcare Fund?
- Sun Pharmaceutical: 13.01%
- J B Chemicals and Pharmaceuticals: 6.23%
- Divis Laboratories: 5.95%
- Max Healthcare Institute: 5.43%
- Cipla: 5.00%
Top 3 sectoral holdings include:
- Healthcare: 93.92%
- Basic Materials: 4.92%
- Others: 1.42%
How risky is investing in Kotak Healthcare Fund?
Who is the fund manager Kotak Healthcare Fund?
What is the minimum investment required in Kotak Healthcare Fund?
How to invest in Kotak Healthcare Fund directly?
- Open Demat Account on Dhan if you don't have one.
- Analyze the fund performance.
- Invest via SIP or Lumpsum.

Invest in
Pay 0% Commission!
+91
Or Scan the QR Code to download the Dhan App




































